The role of the seventh transmembrane region in high affinity binding of a β2-selective agonist TA-2005

Molecular Pharmacology

Volumn 53, Issue 1, 1998, Pages 128-134

  Kikkawa, Hideo ^a,b   Isogaya, Masafumi ^a   Nagao, Taku ^a   Kurose, Hitoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 [(1 HYDROXY 2 ISOPROPYLAMINO)ETHYL] 8 HYDROXYCARBOSTYRIL; 5 [(2 AMINO 1 HYDROXY)ETHYL] 8 HYDROXYCARBOSTYRIL; 5 [1 HYDROXY 2 [N [2 (4 METHOXYPHENYL) 1 METHYLETHYL]AMINO]ETHYL]QUINOLIN 2 (1H) ONE; ADENYLATE CYCLASE; ALANINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARMOTEROL; CHIMERIC PROTEIN; CYCLIC AMP; ISOPRENALINE; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SITE DIRECTED MUTAGENESIS;

EID: 0031939636     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.1.128     Document Type: Article

References (36)

1. Arora KK, Cheng Z, and Catt KJ (1996) Dependence of agonist activation of an aromatic moiety in the DPLIY motif of the gonadotropin-releasing hormone receptor. Mol Endocrinol 10:979-986.
2. 318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation. Endocrinology 137:655-662.
3. 2-adrenergic receptor sequestration. J Biol Chem 269:2790-2795.
4. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, and Trendelenburg U (1994) International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136.
5. Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
6. 102 of the gonadotropin-releasing hormone receptor is a critical determinant of potency for agonists containing C-terminal glycinamide. J Biol Chem 271:15510-15514.
7. Dixon RA, Hill WS, Candelore MR, Rands E, Diehl RE, Marshall MS, Sigal IS, and Strader CD (1989) Genetic analysis of the molecular basis for β-adrenergic receptor subtype specificity. Proteins 6:267-274.
8. Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, and Strader CD (1987) Structural features required for ligand binding to the β-adrenergic receptor. EMBO J 6:3269-3275.
9. 2-adrenergic receptor. Biochemistry 27:1813-1817.
10. 3-adrenergic receptor. Science 245:1118-1121.
11. 1-adrenergic receptor. Proc Natl Acad Sci USA 84:7920-7924.
12. 2-adrenergic receptors. Proc Natl Acad Sci USA 85:9494-9498.
13. 2-adrenergic receptor. J Biol Chem 271:24029-24035.
14. 1-adrenoceptors: consensus update. Pharmacol Rev 47:267-270.
15. Higuchi R (1989) Using PCR to engineer DNA, in PCR Technology (Erlich HA, ed) pp 61-70, Stockton Press, New York.
16. 2-adrenergic receptor ligand binding pocket. Mol Pharmacol 49:1021-1032.
17. 2-agonists. Biol Pharm Bull 17:1047-1052.
18. 2-selective agonists. Br J Pharmacol 121: 1059-1064.
19. 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues. Jpn J Pharmacol 57:175-185.
20. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84:46-50.
21. 2 adrenergic receptor. J Med Chem 39:4406-4420.
22. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
23. 2-adrenergic receptors involves multiple subsites. EMBO J 9:1471-1476.
24. Mizushima S and Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322.
25. Sanger F, Nicklen S, and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
26. Sato Y, Kurose H, Isogaya M, and Nagao T (1996) Molecular characterization of pharmacological properties of T-0509 for β-adrenoceptors. Eur J Pharmacol 315: 363-367.
27. Stiles GL and Lefkowitz RJ (1984) Cardiac adrenergic receptors. Annu Rev Med 35:149-164.
28. Strader CD, Candelore MR, Hill WS, Dixon RA, and Sigal IS (1989a) A single amino acid substitution in the β-adrenergic receptor promotes partial agonist activity from antagonists. J Biol Chem 264:16470-16477.
29. Strader CD, Candelore MR, Hill WS, Sigal IS, and Dixon RA (1989b) Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J Biol Chem 264:13572-13578.
30. Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS, and Dixon RA (1988) Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J Biol Chem 263:10267-10271.
31. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, and Dixon RA (1987) Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci USA 84:4384-4388.
32. 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem 267:3530-3538.
33. 2-adrenoceptor agonist, TA 2005. Eur J Pharmacol 227:403-409.
34. Wilson IA, Niman HL, Houghten RA, Cherenson AR, Connolly ML, and Lerner RA (1984) The structure of an antigenic determinant in a protein. Cell 37:767-778.
35. Wong SK-F, Slaughter C, Ruoho AE, and Ross EM (1988) The catecholamine binding site of the β-adrenergic receptor is formed by juxtaposed membrane-spanning domains. J Biol Chem 263:7925-7928.
36. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, and Sealfon SC (1994) A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol 45: 165-170.